Risher D L, Baccus A L, Townsend S W, Proctor C D
J Natl Med Assoc. 1982 Dec;74(12):1183-7.
A procedure designed to estimate the degree of development of neuronal tolerance to barbiturates is described. With this technique, it has been shown that a subhypnotic (125 mg/kg) peritoneal dose of barbital sodium, given twice daily, over the course of either five or 10 consecutive days, can produce significant elevation in tolerance over that found for analogous groups of saline control animals. Mean tolerances were considerably lower (about 20 percent) than those obtained when the recurrent barbital sodium dosages were at the hypnotic (300 mg/kg) level given once per day for 10 days. The results obtained support the proposition that the method employed is sufficiently sensitive to estimate neuronal tolerance developed as a result of recurrent administrations of subhypnotic dosages of barbiturates when given at adequate frequency and duration.
本文描述了一种用于估计神经元对巴比妥类药物耐受性发展程度的方法。通过这项技术,研究表明,每天两次腹腔注射125mg/kg的次催眠剂量戊巴比妥钠,连续5天或10天给药,与生理盐水对照动物的类似组相比,耐受性会显著提高。平均耐受性比每天一次、连续10天给予催眠剂量(300mg/kg)的戊巴比妥钠时获得的耐受性低得多(约20%)。所获得的结果支持这样一个观点,即当以适当的频率和持续时间给予次催眠剂量的巴比妥类药物时,所采用的方法对估计反复给药后产生的神经元耐受性足够敏感。